These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2937657)

  • 1. Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate.
    Fåhraeus L; Sydsjö A; Wallentin L
    Fertil Steril; 1986 Apr; 45(4):503-6. PubMed ID: 2937657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Fertil Steril; 1984 Jul; 42(1):52-7. PubMed ID: 6724013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolic changes during hormonal treatment of endometriosis.
    Teichmann AT; Cremer P; Wieland H; Kuhn W; Seidel D
    Maturitas; 1988 May; 10(1):27-33. PubMed ID: 2969446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
    Telimaa S; Penttilä I; Puolakka J; Rönnberg L; Kauppila A
    Fertil Steril; 1989 Jul; 52(1):31-5. PubMed ID: 2526031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medroxyprogesterone acetate and lipid metabolic changes.
    Teichmann AT; Wander HE; Cremer P; Wieland H; Kuhn W; Nagel GA; Seidel D
    Arzneimittelforschung; 1987 May; 37(5):573-7. PubMed ID: 2956958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
    Telimaa S; Puolakka J; Rönnberg L; Kauppila A
    Gynecol Endocrinol; 1987 Mar; 1(1):13-23. PubMed ID: 2972167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
    Crona N; Enk L; Samsioe G; Silfverstolpe G; Skryten A
    Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):97-105. PubMed ID: 6227506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
    Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer].
    Brockerhoff P; Grill HJ; Holzer A; Kreienberg R; Pollow K; Schicketanz KH; Schwarz V; Rathgen GH
    Gynakol Rundsch; 1991; 31(4):189-200. PubMed ID: 1839014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of endometriosis with oral medroxyprogesterone acetate.
    Moghissi KS; Boyce CR
    Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
    Huovinen K; Tikkanen MJ; Autio S; Härkönen T; Lommi L; Varonen S; Wilska ML
    Acta Obstet Gynecol Scand; 1991; 70(4-5):349-54. PubMed ID: 1836088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of large-dose progesterone on plasma levels of lipids, lipoproteins and apolipoproteins in males.
    Chen JJ; Berlin FS; Margolis S
    J Endocrinol Invest; 1986 Aug; 9(4):281-5. PubMed ID: 2946755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin reversal of ureteral endometriosis.
    Gantt PA; Hunt JB; McDonough PG
    Obstet Gynecol; 1981 May; 57(5):665-7. PubMed ID: 6452593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
    Lehtonen A; Grönroos M; Marniemi J; Peltonen P; Mäntylä M; Niskanen J; Rautio A; Hietanen E
    Horm Metab Res; 1985 Jan; 17(1):32-4. PubMed ID: 3155702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subfractions of high density lipoproteins in relation to age].
    Richter V; Rassoul F; Purcz T; Faki R
    Z Gerontol; 1990; 23(1):50-5. PubMed ID: 2327147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.